A pooled mutant KRAS peptide vaccine activates polyfunctional T cell responses in patients with resected pancreatic cancer

被引：3
|
作者：
Huff, Amanda L.
Haldar, Saurav D.
Davis-Marcisak, Emily
Heumann, Thatcher
Longway, Gabriella
Hernandez, Alexei
Konig, Maximillian F.
Mog, Brian
Danilova, Ludmila
Kagohara, Luciane
Nauroth, Julie M.
Thomas, Amy M.
Fertig, Elana J.
Ho, Won Jin
Jaffee, Elizabeth M.
Azad, Nilo
Zaidi, Neeha
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 08期
关键词：
D O I：
10.1158/1538-7445.AM2023-LB197
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [41] A novel intranasal peptide vaccine inhibits non-small cell lung cancer with KRAS mutation
    Su He Wang
    Zhengyi Cao
    Mohammad Farazuddin
    Jesse Chen
    Katarzyna W. Janczak
    Shengzhuang Tang
    Jayme Cannon
    James R. Baker
    Cancer Gene Therapy, 2024, 31 : 464 - 471
  • [42] Prevention of non-small cell lung cancer with kras mutation using a novel peptide vaccine
    Wang, Suhe
    Cao, Zhengyi
    Chen, Jesse
    Katarzyna, Janczak
    Baker, James
    CANCER RESEARCH, 2022, 82 (12)
  • [43] A novel intranasal peptide vaccine inhibits non-small cell lung cancer with KRAS mutation
    Wang, Su He
    Cao, Zhengyi
    Farazuddin, Mohammad
    Chen, Jesse
    Janczak, Katarzyna W.
    Tang, Shengzhuang
    Cannon, Jayme
    Baker Jr, James R.
    CANCER GENE THERAPY, 2024, 31 (03) : 464 - 471
  • [44] Triggering of T cell-mediated immune responses by allogenic tumor cell vaccine in patients with oral cancer
    Devarapu, Satish K.
    Sharma, Suresh C.
    Das, Satya N.
    IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY, 2006, 28 (03) : 387 - 395
  • [45] Oncogenic KRAS inhibition with ADT-007 primes T cell responses in pancreatic ductal adenocarcinoma
    Foote, Jeremy B.
    Mattox, Tyler E.
    Keeton, Adam B.
    Purnachandra, Ganji N.
    Maxuitenko, Yulia
    Chen, Xi
    Valiyaveettil, Jacob
    Buchsbaum, Donald J.
    Piazza, Gary A.
    El-Rayes, Bassel F.
    CANCER RESEARCH, 2023, 83 (07)
  • [46] Integrity of cell-free DNA in plasma as a useful biomarker for responses to peptide vaccine in ovarian cancer patients
    Waki, Kayoko
    Yamada, Akira
    CANCER SCIENCE, 2018, 109 : 838 - 838
  • [47] Monitoring T-cell responses in cancer vaccine clinical trials
    Malyguine, Anatob M.
    Shafer-Weaver, Kimberly A.
    Zaritskaya, Liubov
    Strobl, Susan L.
    Gregory, Melissa K.
    Baseler, Michael
    JOURNAL OF IMMUNOTHERAPY, 2007, 30 (08) : 863 - 864
  • [48] Immune monitoring of T-cell responses in cancer vaccine development
    Keilhoz, U
    Martus, P
    Scheibenbogen, C
    CLINICAL CANCER RESEARCH, 2006, 12 (07) : 2346S - 2352S
  • [49] Impact of personalized peptide neoantigen vaccines on immunologic responses in patients with pancreatic cancer
    Hu, Landian
    Zhang, Yuchao
    Kong, Xiangyin
    Wu, Zhenchuan
    Wang, Hailong
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [50] Phase I study of lapatinib plus trametinib in patients with KRAS-mutant colorectal, non-small cell lung, and pancreatic cancer
    Huijberts, Sanne C. F. A.
    van Geel, Robin M. J. M.
    van Brummelen, Emilie M. J.
    Opdam, Frans L.
    Marchetti, Serena
    Steeghs, Neeltje
    Pulleman, Saskia
    Thijssen, Bas
    Rosing, Hilde
    Monkhorst, Kim
    Huitema, Alwin D. R.
    Beijnen, Jos H.
    Bernards, Rene
    Schellens, Jan H. M.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2020, 85 (05) : 917 - 930
12345